Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Alaa Halawa currently holds 80,000 shares of Neumora Therapeutics, Inc. (NMRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alaa Halawa has been a net neutral trader of NMRA stock. They have purchased $0 and sold $0 worth of shares.
Alaa Halawa's most recent insider trade was on May 27, 2026, when they sold 80,000 shares at $0.00 per share.
Alaa Halawa serves as Executive at Neumora Therapeutics, Inc. (NMRA). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Alaa Halawa holds the position of Executive at Neumora Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Alaa Halawa has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Alaa Halawa was on May 27, 2026, when they purchased $0 worth of NMRA shares. This transaction involved 80,000 shares at N/A per share.
Alaa Halawa currently owns 80,000 shares of Neumora Therapeutics, Inc. (NMRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Alaa Halawa's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Alaa Halawa has 3 Form 4 filings on record as an insider at Neumora Therapeutics, Inc..
Set alerts for Alaa Halawa and 40,000+ other insiders.